Publications

Dr. Ricardo Valladares Discusses Infant Microbiome and Allergy Links with Alba Health

Siolta Therapeutics and Cowellnex Enter Joint Research Agreement

Nexilico and Siolta Therapeutics Enter Collaboration Agreement to Address Necrotizing Enterocolitis

Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development of STMC-103H for Allergic Disease Prevention

Siolta Therapeutics Doses First Newborn in Groundbreaking Phase 2 Trial of STMC-103H for the Prevention of Atopic Diseases

Finding the right fit: evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data